Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Prostate Cancer Cells

PSA Drop Seen with New Prostate Cancer Drug

Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator, data from a preliminary clinical study showed.

During 12 weeks of treatment with galeterone, prostate-specific antigen (PSA) declined by at least 30% in 24 of 49 patients, 11 of whom had declines… PSA Drop Seen with New Prostate Cancer Drug   



Dormant prostate cancer cells may be reawakened by factors produced in inflammatory cells

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. Understanding this mechanism of action may allow researchers to intervene prior to disease progression.

“Understanding how and why dormant cells… Dormant prostate cancer cells may be reawakened by factors produced in inflammatory cells   



high-precision surgical robot1 - diagnostic test2 - prostate cancer treatment5 - postvoid dribbling2 - bone decay1 - psa velocity screening1 - adolescent overweight1 - androgen deprivation therapy5 - vascular endothelial growth factor1 - internal and external genitalia1 - androgen receptor1 - renal disease3 - urethral pain1 - robot-assisted surgery for prostate cancer1 - public library of science1 - alpharadin tm1 - klotho deficiency1 - urine tests1 - clinical trials1 - iga nephropathy2 - radiotherapy3 - bladder infection2 - ips cells1 - ontario health insurance plan1 - pyuria1 - adt3 - cardiovascular disease5 - ralp1 - quality of life1 - avandia1 -